SUBSCRIBE
SUBSCRIBE
News   Drug Development

UK Body Backs Limited Use of Eli Lilly and Company (JOBS), Daiichi Sankyo Co Ltd. Anti-Clot Drug

September 4, 2009 | 
1 min read
Bookmark and Share

Reuters -- Eli Lilly and Daiichi Sankyo's anti-clotting drug prasugrel has been recommended for limited use on Britain's state-run National Health Service.
Clinical research Postmarket research Europe
Eli Lilly and Company Daiichi Sankyo
MORE ON THIS TOPIC
Poster sketch image artwork photo collage of body language finger showing gesture symbol thumb down dislike dissatisfied minus no opinion.
Sickle cell disease
Pfizer’s $5.4B GBT Bet Disappoints Again as Sickle Cell Therapy Fails in Phase III
August 18, 2025
 · 
2 min read
 · 
Tristan Manalac
US Dollar coin and EU currencies on weighing scale against Unated States and European Union flags as symbol of trade war, economic conflict. Selective focus on Dollar.
Drug pricing
Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy
August 14, 2025
 · 
3 min read
 · 
Annalee Armstrong
Indianapolis, U.S. - April 16, 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals VII
Obesity
Eli Lilly Keeps Obesity Pipeline Fresh With $1.3B Superluminal Partnership
August 14, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Contemporary art collage of hand holding an arrow showing fall. Modern design. Copy space.
Pipeline
Schrödinger Cans Early-Stage Blood Cancer Drug After Two Patient Deaths
August 14, 2025
 · 
2 min read
 · 
Tristan Manalac